450 related articles for article (PubMed ID: 23047694)
1. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
[TBL] [Abstract][Full Text] [Related]
2. Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.
Bernardo BC; Gao XM; Tham YK; Kiriazis H; Winbanks CE; Ooi JY; Boey EJ; Obad S; Kauppinen S; Gregorevic P; Du XJ; Lin RC; McMullen JR
PLoS One; 2014; 9(2):e90337. PubMed ID: 24587330
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
[TBL] [Abstract][Full Text] [Related]
4. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.
Bernardo BC; Nguyen SS; Winbanks CE; Gao XM; Boey EJ; Tham YK; Kiriazis H; Ooi JY; Porrello ER; Igoor S; Thomas CJ; Gregorevic P; Lin RC; Du XJ; McMullen JR
FASEB J; 2014 Dec; 28(12):5097-110. PubMed ID: 25145628
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
Bernardo BC; Yildiz GS; Kiriazis H; Harmawan CA; Tai CMK; Ritchie RH; McMullen JR
Cells; 2022 Oct; 11(19):. PubMed ID: 36231079
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.
Rottiers V; Obad S; Petri A; McGarrah R; Lindholm MW; Black JC; Sinha S; Goody RJ; Lawrence MS; deLemos AS; Hansen HF; Whittaker S; Henry S; Brookes R; Najafi-Shoushtari SH; Chung RT; Whetstine JR; Gerszten RE; Kauppinen S; Näär AM
Sci Transl Med; 2013 Nov; 5(212):212ra162. PubMed ID: 24259050
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.
Martinez EC; Lilyanna S; Wang P; Vardy LA; Jiang X; Armugam A; Jeyaseelan K; Richards AM
J Mol Cell Cardiol; 2017 Nov; 112():27-39. PubMed ID: 28865712
[TBL] [Abstract][Full Text] [Related]
10. AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
Hinkel R; Batkai S; Bähr A; Bozoglu T; Straub S; Borchert T; Viereck J; Howe A; Hornaschewitz N; Oberberger L; Jurisch V; Kozlik-Feldmann R; Freudenthal F; Ziegler T; Weber C; Sperandio M; Engelhardt S; Laugwitz KL; Moretti A; Klymiuk N; Thum T; Kupatt C
J Am Coll Cardiol; 2021 Jun; 77(23):2923-2935. PubMed ID: 34112319
[TBL] [Abstract][Full Text] [Related]
11. AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury.
Hinkel R; Ramanujam D; Kaczmarek V; Howe A; Klett K; Beck C; Dueck A; Thum T; Laugwitz KL; Maegdefessel L; Weber C; Kupatt C; Engelhardt S
J Am Coll Cardiol; 2020 Apr; 75(15):1788-1800. PubMed ID: 32299591
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
Bernardo BC; Nguyen SS; Gao XM; Tham YK; Ooi JY; Patterson NL; Kiriazis H; Su Y; Thomas CJ; Lin RC; Du XJ; McMullen JR
Sci Rep; 2016 Mar; 6():22442. PubMed ID: 26928825
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Cell Type-Specific Effects of MicroRNA-92a Provides Novel Insights Into Target Regulation and Mechanism of Action.
Rogg EM; Abplanalp WT; Bischof C; John D; Schulz MH; Krishnan J; Fischer A; Poluzzi C; Schaefer L; Bonauer A; Zeiher AM; Dimmeler S
Circulation; 2018 Nov; 138(22):2545-2558. PubMed ID: 30571345
[TBL] [Abstract][Full Text] [Related]
14. LNA-mediated microRNA silencing in non-human primates.
Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-15 protects against cardiac ischemic injury.
Hullinger TG; Montgomery RL; Seto AG; Dickinson BA; Semus HM; Lynch JM; Dalby CM; Robinson K; Stack C; Latimer PA; Hare JM; Olson EN; van Rooij E
Circ Res; 2012 Jan; 110(1):71-81. PubMed ID: 22052914
[TBL] [Abstract][Full Text] [Related]
17. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.
Patrick DM; Montgomery RL; Qi X; Obad S; Kauppinen S; Hill JA; van Rooij E; Olson EN
J Clin Invest; 2010 Nov; 120(11):3912-6. PubMed ID: 20978354
[TBL] [Abstract][Full Text] [Related]
18. miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models.
Pan Z; Sun X; Ren J; Li X; Gao X; Lu C; Zhang Y; Sun H; Wang Y; Wang H; Wang J; Xie L; Lu Y; Yang B
PLoS One; 2012; 7(11):e50515. PubMed ID: 23226300
[TBL] [Abstract][Full Text] [Related]
19. Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity.
Naseri Z; Oskuee RK; Forouzandeh-Moghadam M; Jaafari MR
Stem Cell Rev Rep; 2020 Jun; 16(3):541-556. PubMed ID: 31898802
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]